US stocks staged a remarkable comeback during afternoon trading on Tuesday, offering a glimmer of hope to investors. The reason? Growing optimism that the ongoing US government shutdown might soon come to an end.
The Dow Jones Industrial Average soared by over 550 points, while the S&P 500 gained approximately 0.3%, with a majority of its components trading higher. Traders shifted their focus to blue-chip and cyclical stocks, anticipating a funding deal to pass the House this week.
But here's where it gets controversial: the progress made in the Senate to reopen the government had a mixed impact. While sentiment lifted in economically sensitive sectors, the tech-heavy Nasdaq took a hit, slipping around 0.2%. AI-exposed stocks faced renewed pressure, with SoftBank's sale of its entire $5.8 billion Nvidia stake weighing heavily on the sector. Nvidia shares fell by about 3%, while Micron, Oracle, and Palantir each lost more than 2%.
The healthcare sector, however, emerged as a bright spot, with leaders like Merck (4%), Amgen (3.1%), and Johnson & Johnson (2.2%) driving the Dow higher. Investors are hopeful that the resumption of government operations will release delayed economic data, providing a much-needed boost to near-term growth.
And this is the part most people miss: the market's reaction to the potential end of the shutdown is a delicate balance. While some sectors thrive on the optimism, others remain cautious. The tech sector, in particular, seems to be treading carefully, perhaps awaiting more concrete developments before rejoining the rally.
So, what's your take on this? Do you think the market's response is justified, or is it too early to celebrate? Share your thoughts in the comments below and let's spark a discussion!
